[Non-AIDS-related malignancies: prognostic and treatment].
Malignant tumors currently rank among the leading cause of morbidity and mortality in patients infected with HIV. The survival is increased for patients who benefits from better control of viral replication and from progress in prevention of opportunistic infections. These patients are thus exposed to an increased risk of cancer. The most frequent malignant tumors not associated with AIDS stage are Hodgkin disease, germ-cell tumors, cutaneous cancer, head and neck cancer and lung cancer. The goal of this chapter is to describe the clinical and histological pattern of these malignant tumors, and to propose therapeutic guidelines for HIV patients with cancer.
Spano
Jean-Philippe
JP
Hôpital Avicenne, Département d'oncologie médicale, 125, rue de Stalingrad, 93000 Bobigny, France. jean-hilippe.spano@avc.ap-hop-paris.fr
Faivre
Sandrine
S
D018237:Germinoma / Q000209:etiology / Q000628:therapy*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006258:Head and Neck Neoplasms / Q000209:etiology / Q000628:therapy*; D006689:Hodgkin Disease / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000209:etiology / Q000628:therapy*; D011379:Prognosis; D012878:Skin Neoplasms / Q000209:etiology / Q000628:therapy*; D013534:Survival